Brief: Diaxonhit to raise 8.9 mln euros for Eurobio acquisition

Eurobio Scientific SA

30/01/2017 06:30

Jan 30 (Reuters) - Diaxonhit SA  ALEHT.PA : 
    * Capital increase of up to 8.9 million euros ($9.5 million) 
in connection with the acquisition of Eurobio 
    * Offer period from Jan 30 to Feb 3, 2017 included 
    * Subscription price of 0.22 euros per share 
    * Underwriting commitments of several investors to the 
extent of approximately 85.9% of the capital increase 
    * The offering of the offered shares is part of a financing 
of approximately 15 million euros for the most part directly 
related to the acquisition of Capforce Plus 
 
Source text for Eikon:  ID:nNDL549HWM  
Further company coverage:  ALEHT.PA  
 
($1 = 0.9328 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))